AsOf

Recorded or changed on this day 2026-11-08

45,151–45,200 of 46,534 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 258,094,815 shares
Vertex Pharmaceuticals shares outstanding: 258,094,815 shares, claim clm_AF5A88F5634C · ended · superseded by clm_63DBD5A352EB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 205,997,844 shares
Vertex Pharmaceuticals shares outstanding: 205,997,844 shares, claim clm_AFEA9E22E536 · ended · superseded by clm_47B306C70D65 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 659,200,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 659,200,000 United States dollar, claim clm_AFFDEC5591E2 · ended · superseded by clm_D0A8C98B8F52 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 189,052,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 189,052,000 United States…, claim clm_B00D340EC942 · ended · superseded by clm_CEDFEA389A43 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 259,268,593 shares
Vertex Pharmaceuticals shares outstanding: 259,268,593 shares, claim clm_B0DC25435A02 · ended · superseded by clm_987CBFB7A223 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -3,593,600,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -3,593,600,000 United States dollar, claim clm_B131D7103BCE · ended · superseded by clm_E844FD7AD190 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · revenue · 12,001,300,000 United States dollar
Vertex Pharmaceuticals revenue: 12,001,300,000 United States dollar, claim clm_B151EC07FDAE · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 267,923,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 267,923,000 United States dollar, claim clm_B1D95D9229AF · ended · superseded by clm_FC85126D5926 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · net income · -535,600,000 United States dollar
Vertex Pharmaceuticals net income: -535,600,000 United States dollar, claim clm_B3A7B0C585DF · ended · superseded by clm_406C31565DD9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 215,707,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 215,707,000 United States dollar, claim clm_B3AC75D212CF · ended · superseded by clm_85DA72CF3BE5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 1,500,008,000 United States dollar
Vertex Pharmaceuticals total equity: 1,500,008,000 United States dollar, claim clm_B3CDEA1413F9 · ended · superseded by clm_8500F4409507 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 5,084,800,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 5,084,800,000 United States dollar, claim clm_B4475729CD2A · ended · superseded by clm_379D75861ABB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 289,451,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 289,451,000 United States…, claim clm_B48FA71C174F · ended · superseded by clm_5202D9005278 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · listed on · Nasdaq
Vertex Pharmaceuticals listed on: Nasdaq, claim clm_B527C44C89E1 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 173,604,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 173,604,000 United States…, claim clm_B5FD1F0507D0 · ended · superseded by clm_B00D340EC942 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 718,563,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 718,563,000 United States dollar, claim clm_B60FF5975D9F · ended · superseded by clm_C9477D430932 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 15,470,200,000 United States dollar
Vertex Pharmaceuticals total equity: 15,470,200,000 United States dollar, claim clm_B62228AD3B5C · ended · superseded by clm_7E2CD975D5FB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 9,530,708,000 United States dollar
Vertex Pharmaceuticals total equity: 9,530,708,000 United States dollar, claim clm_B630EC176E52 · ended · superseded by clm_1E5426FCEFF5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · -466,879,000 United States dollar
Vertex Pharmaceuticals operating income: -466,879,000 United States dollar, claim clm_B6F6CDFC9E0A · ended · superseded by clm_C74861030CDE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 254,034,190 shares
Vertex Pharmaceuticals shares outstanding: 254,034,190 shares, claim clm_B7B98F7F000A · ended · superseded by clm_EA3BCAE7F8D0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 667,434,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 667,434,000 United States dollar, claim clm_B82BAA2538E3 · ended · superseded by clm_D8AA2809B20A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 1,138,100,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 1,138,100,000 United States dollar, claim clm_B8F364B1BB32 · ended · superseded by clm_3B40C30B5BFE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 259,428,394 shares
Vertex Pharmaceuticals shares outstanding: 259,428,394 shares, claim clm_B929FA328F8E · ended · superseded by clm_02288182B0BB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 1,211,975,000 United States dollar
Vertex Pharmaceuticals revenue: 1,211,975,000 United States dollar, claim clm_B995587F5A51 · ended · superseded by clm_76E972477DD6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 1,032,336,000 United States dollar
Vertex Pharmaceuticals revenue: 1,032,336,000 United States dollar, claim clm_B9A0D3A94E4B · ended · superseded by clm_3048F4177FBD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 9,158,000,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 9,158,000,000 United States dollar, claim clm_BA38CFEB0E56 · ended · superseded by clm_C4593DB240D3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 1,793,370,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 1,793,370,000 United States dollar, claim clm_BA95AEDBE337 · ended · superseded by clm_6BB57BAD5620 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 2,686,228,000 United States dollar
Vertex Pharmaceuticals total equity: 2,686,228,000 United States dollar, claim clm_BDF180B6AD97 · ended · superseded by clm_815A8BEADE9D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 1,038,100,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 1,038,100,000 United States dollar, claim clm_BE04B4442DA0 · ended · superseded by clm_472C99A37BC6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 143,581,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 143,581,000 United States…, claim clm_BEF2FDEB0A7D · ended · superseded by clm_807DBFE23E9F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 232,812,301 shares
Vertex Pharmaceuticals shares outstanding: 232,812,301 shares, claim clm_BEFDB3212DCF · ended · superseded by clm_EB4B38E18AF2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 258,865,671 shares
Vertex Pharmaceuticals shares outstanding: 258,865,671 shares, claim clm_BF1FDA0B7CEF · ended · superseded by clm_B929FA328F8E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 7,519,242,000 United States dollar
Vertex Pharmaceuticals total equity: 7,519,242,000 United States dollar, claim clm_BF61DD66F463 · ended · superseded by clm_9E3B341B6DD1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 268,631,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 268,631,000 United States dollar, claim clm_BFDA13517B9A · ended · superseded by clm_391AC2F64417 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 8,893,201,000 United States dollar
Vertex Pharmaceuticals total assets: 8,893,201,000 United States dollar, claim clm_C020ABBFE645 · ended · superseded by clm_194411381C8C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 91,590,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 91,590,000 United States dollar, claim clm_C0D5B06E732F · ended · superseded by clm_76A2F176E63C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 6,461,654,000 United States dollar
Vertex Pharmaceuticals total equity: 6,461,654,000 United States dollar, claim clm_C1525E494CB5 · ended · superseded by clm_BF61DD66F463 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -1,071,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -1,071,000 United States dollar, claim clm_C200AAD1B7D9 · ended · superseded by clm_140090973306 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 887,826,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 887,826,000 United States dollar, claim clm_C212C614D9A6 · ended · superseded by clm_1F15DBA70DE0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 1,032,900,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 1,032,900,000 United States dollar, claim clm_C2590A2F1C6C · ended · superseded by clm_2FE795B3AF8B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 4,620,840,000 United States dollar
Vertex Pharmaceuticals total assets: 4,620,840,000 United States dollar, claim clm_C2CDDE4D143F · ended · superseded by clm_E43D77EF5B44 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 271,008,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 271,008,000 United States…, claim clm_C3B5C13564FF · ended · superseded by clm_77AD1FA686BE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 1,888,829,000 United States dollar
Vertex Pharmaceuticals total assets: 1,888,829,000 United States dollar, claim clm_C3D8BF48EB7E · ended · superseded by clm_CE17430C757C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 4,580,100,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 4,580,100,000 United States dollar, claim clm_C4593DB240D3 · ended · superseded by clm_17107958B9E8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · research and development · 1,324,625,000 United States dollar
Vertex Pharmaceuticals research and development: 1,324,625,000 United States dollar, claim clm_C5B2018B6129 · ended · superseded by clm_EF7099311C58 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 330,510,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 330,510,000 United States…, claim clm_C5F9C8D7CC95 · ended · superseded by clm_1A5BF9CE8A15 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · 9,936,000 United States dollar
Vertex Pharmaceuticals operating income: 9,936,000 United States dollar, claim clm_C74861030CDE · ended · superseded by clm_03E98C0A4208 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 11,751,808,000 United States dollar
Vertex Pharmaceuticals total assets: 11,751,808,000 United States dollar, claim clm_C7952DDAD12A · ended · superseded by clm_934E3BFFB8E5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 625,259,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 625,259,000 United States dollar, claim clm_C9477D430932 · ended · superseded by clm_ECB58BC2FBDB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 218,188,628 shares
Vertex Pharmaceuticals shares outstanding: 218,188,628 shares, claim clm_C9B18373B83D · ended · superseded by clm_F2071C89A470 · 1 source (1 primary) · conf 0.95

What the statuses mean